Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/BIOVENTRIX, INC./ DRS/A

SEC Filing · DRS/A

BIOVENTRIX, INC.

BVXXNASDAQEQUITYCurrent

SEC Filing

Filed Dec 12, 2025Accepted Dec 12, 2025, 11:56 AM ESTCIK 1283259Accession 0001493152-25-027406
View company →Permanent SEC source ↗
Share

Company context

We are a medical device company focused on developing, manufacturing and commercializing proprietary devices to restore left ventricular function in heart failure patients with reduced ejection fraction (“HFrEF”).

Current securities

BVXXNASDAQ · EQUITY · Current

Recent company filings

  1. D/A filingSep 9, 2026
  2. D/A filingSep 1, 2026
  3. S-1/A filingMay 29, 2026
  4. S-1/A filingMay 15, 2026
  5. D filingApr 24, 2026

As-filed source

Primary evidence
As filedOpen full document ↗